Pariyarath Ramesh Menon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pariyarath Ramesh Menon has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Abhinav Singh Chauhan
AIIMS
1 shared publicationAkshay Kumar Bisoi
CardioThoracic and Vascular Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, 110029, India
1 shared publication- Akshay Kumar Bisoi
Department of CTVS, All India Institute of Medical Sciences, New Delhi, India
1 shared publication Andsudha Rathna Prabhu
MediScans, Chennai, India
1 shared publicationAparna Chakravarty
Department of Pediatrics, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard University, New Delhi, India
1 shared publicationB. P. Ravikumar
Mamata Medical College
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in Discover Pediatrics
- Vol. 1 (1) , 5
A narrative review of sildenafil dosing and monitoring by indication in neonatal pulmonary hypertension
Pulmonary hypertension in the neonate is a leading contributor to hypoxemic respiratory failure and carries substantial mortality across diverse etiologies, including persistent pulmonary hypertension of the newborn (PPHN), bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), and the early postoperative course after surgery for congenital heart disease. Congenital diaphragmatic hernia, which frequently involves complex, multifactorial physiology, is considered outside the scope of this review. Inhaled nitric oxide remains the established first-line selective pulmonary vasodilator but is unavailable, ineffective, or impractical in a substantial proportion of clinical scenarios, particularly in resource-limited neonatal units. Sildenafil, an orally and intravenously bioavailable phosphodiesterase type 5 (PDE5) inhibitor, has become the most widely used adjunctive or alternative pulmonary vasodilator in the neonatal intensive care unit, despite remaining off-label for this indication. This narrative review consolidates contemporary, neonatal-specific evidence on the use of sildenafil in newborns and young infants. It focuses on developmental pharmacokinetics, evidence-based oral and intravenous dosing regimens for the principal indications, a structured framework for hemodynamic and echocardiographic monitoring, an indication-stratified clinical algorithm, and the safety profile relevant to this age group. The review also addresses the practical implications of the United States Food and Drug Administration warning derived from the STARTS-2 trial for the neonatal population, summarises the differing positions of international regulators, and outlines persistent knowledge gaps. Although the available evidence supports sildenafil as a clinically useful adjunct to or substitute for inhaled nitric oxide in neonates, particularly in resource-limited settings where iNO is unavailable and only with careful hemodynamic monitoring, individualized dosing, structured monitoring, and explicit weaning protocols remain essential to its safe and effective use.
- 18 September 2026
- Published by Springer Nature in Discover Pediatrics
- Vol. 1 (1) , 5
Open AccessA narrative review of sildenafil dosing and monitoring by indication in neonatal pulmonary hypertension
Pulmonary hypertension in the neonate is a leading contributor to hypoxemic respiratory failure and carries substantial mortality across diverse etiologies, including persistent pulmonary hypertension of the newborn (PPHN), bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), and the early postoperative course after surgery for congenital heart disease. Congenital diaphragmatic hernia, which frequently involves complex, multifactorial physiology, is considered outside the scope of this review. Inhaled nitric oxide remains the established first-line selective pulmonary vasodilator but is unavailable, ineffective, or impractical in a substantial proportion of clinical scenarios, particularly in resource-limited neonatal units. Sildenafil, an orally and intravenously bioavailable phosphodiesterase type 5 (PDE5) inhibitor, has become the most widely used adjunctive or alternative pulmonary vasodilator in the neonatal intensive care unit, despite remaining off-label for this indication. This narrative review consolidates contemporary, neonatal-specific evidence on the use of sildenafil in newborns and young infants. It focuses on developmental pharmacokinetics, evidence-based oral and intravenous dosing regimens for the principal indications, a structured framework for hemodynamic and echocardiographic monitoring, an indication-stratified clinical algorithm, and the safety profile relevant to this age group. The review also addresses the practical implications of the United States Food and Drug Administration warning derived from the STARTS-2 trial for the neonatal population, summarises the differing positions of international regulators, and outlines persistent knowledge gaps. Although the available evidence supports sildenafil as a clinically useful adjunct to or substitute for inhaled nitric oxide in neonates, particularly in resource-limited settings where iNO is unavailable and only with careful hemodynamic monitoring, individualized dosing, structured monitoring, and explicit weaning protocols remain essential to its safe and effective use.
- 20 January 2022
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 89 (5) , 523
How to Reopen Schools in a Flipped Manner Without a Flop
- 20 January 2022
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 89 (5) , 523
How to Reopen Schools in a Flipped Manner Without a Flop
- 1 March 2021
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 37 (2) , 234-235
Surgical repair of coarctation of aorta harbinger of newer complications??
- 1 March 2021
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 37 (2) , 234-235
Surgical repair of coarctation of aorta harbinger of newer complications??
- 18 September 2020
- Published by Springer Nature in Indian Pediatrics
- Vol. 57 (9) , 869-870
Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History
- 18 September 2020
- Published by Springer Nature in Indian Pediatrics
- Vol. 57 (9) , 869-870
Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History
- Open Access
- 17 April 2019
- Published by F1000 Research Ltd in F1000Research
- Vol. 8, 507
Case Report: Favoring biventricular repair beyond the conventional boundaries with primary arterial switch operation in a young adult
Transposition of great arteries (TGA) presents in neonates or in infancy. We report a case of TGA with ventricular septal defect (VSD) and pulmonary stenosis (PS) in an adult male patient of 23 years age. Arterial switch operation with VSD closure and neo-aortic valve replacement was done. The patient recovered well in the post-operative period. In adult patients, conversion from atrial to arterial switch has been widely reported, both directly and after prior pulmonary artery banding in two stages, but primary arterial switch for TGA has not been reported previously. In this patient there was a benefit of having a large VSD and severe PS.
- 17 April 2019
- Published by F1000 Research Ltd in F1000Research
- Vol. 8, 507
Open AccessCase Report: Favoring biventricular repair beyond the conventional boundaries with primary arterial switch operation in a young adult
Transposition of great arteries (TGA) presents in neonates or in infancy. We report a case of TGA with ventricular septal defect (VSD) and pulmonary stenosis (PS) in an adult male patient of 23 years age. Arterial switch operation with VSD closure and neo-aortic valve replacement was done. The patient recovered well in the post-operative period. In adult patients, conversion from atrial to arterial switch has been widely reported, both directly and after prior pulmonary artery banding in two stages, but primary arterial switch for TGA has not been reported previously. In this patient there was a benefit of having a large VSD and severe PS.
- 4 December 2018
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 86 (2) , 109-110
The Fluid Frontier in the Lungs: Scoring it to Predict its Flow
- 4 December 2018
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 86 (2) , 109-110
The Fluid Frontier in the Lungs: Scoring it to Predict its Flow
- 27 November 2018
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 35 (2) , 257-258
A learning experience in the use of high-frequency oscillatory ventilation in infants post-cardiac surgery
- 27 November 2018
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 35 (2) , 257-258
A learning experience in the use of high-frequency oscillatory ventilation in infants post-cardiac surgery
- Open Access
- 27 January 2014
- Published by F1000 Research Ltd in F1000Research
- Vol. 3
Case Report: An unusual clinical presentation of Kikuchi’s disease: a case report
Introduction Kikuchi’s disease is usually a benign condition presenting with fever and lymphadenopathy. Rarely, the severe form of this disease can have an unusual presentation. Case Report We report a case of 9 year old girl, a resident of Kerala (South India) with no significant past medical history, who presented with fever of 8 days with facial puffiness. She had tender cervical lymphadenopathy. Two days after admission, her condition worsened with venous congestion of the face and neck, throbbing headache, dyspnea and she developed seizures. Very soon, she developed pericarditis with cardiogenic shock and required adrenaline support. Lymph node biopsy confirmed Kikuchi’s disease. The possibility of superior vena cava (SVC) obstruction due to mediastinal lymphadenopathy was considered and treated with steroids following which the child showed a dramatic improvement. The child also had four of the American Rheumatism Association (ARA) diagnostic criteria for systemic lupus erythematosus (SLE) (viz., serositis, seizures, hematological abnormalities and antinuclear antibodies (ANA) positivity. Conclusion Although Kikuchi’s disease is a self-limiting condition, it is important to consider this possibility in any patient who fits the typical clinical scenario to avoid unnecessary workup. An unusually severe form of Kikuchi’s disease can have a presentation like SVC obstruction syndrome due to enlarged mediastinal lymph nodes. Hence, timely recognition of this condition and prompt institution of steroid therapy will result in a dramatic clinical response.
- 27 January 2014
- Published by F1000 Research Ltd in F1000Research
- Vol. 3
Open AccessCase Report: An unusual clinical presentation of Kikuchi’s disease: a case report
Introduction Kikuchi’s disease is usually a benign condition presenting with fever and lymphadenopathy. Rarely, the severe form of this disease can have an unusual presentation. Case Report We report a case of 9 year old girl, a resident of Kerala (South India) with no significant past medical history, who presented with fever of 8 days with facial puffiness. She had tender cervical lymphadenopathy. Two days after admission, her condition worsened with venous congestion of the face and neck, throbbing headache, dyspnea and she developed seizures. Very soon, she developed pericarditis with cardiogenic shock and required adrenaline support. Lymph node biopsy confirmed Kikuchi’s disease. The possibility of superior vena cava (SVC) obstruction due to mediastinal lymphadenopathy was considered and treated with steroids following which the child showed a dramatic improvement. The child also had four of the American Rheumatism Association (ARA) diagnostic criteria for systemic lupus erythematosus (SLE) (viz., serositis, seizures, hematological abnormalities and antinuclear antibodies (ANA) positivity. Conclusion Although Kikuchi’s disease is a self-limiting condition, it is important to consider this possibility in any patient who fits the typical clinical scenario to avoid unnecessary workup. An unusually severe form of Kikuchi’s disease can have a presentation like SVC obstruction syndrome due to enlarged mediastinal lymph nodes. Hence, timely recognition of this condition and prompt institution of steroid therapy will result in a dramatic clinical response.
- Open Access
- 10 December 2011
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 79 (4) , 549
The Stethoscope & The Scalpel: Jimmy Mathew (ed)
- 10 December 2011
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 79 (4) , 549
Open AccessThe Stethoscope & The Scalpel: Jimmy Mathew (ed)